Perspective Therapeutics (CATX) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Perspective Therapeutics (CATX) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 16.91% |
| 10 | Perspective Therapeutics | 384.88 Mn | 384.88 Mn | - | -103.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.60% |
| Mar 31, 2026 | 79.80% |
| Dec 31, 2025 | 8,489.27% |
| Sep 30, 2025 | 74.93% |
| Jun 30, 2025 | 82.32% |
| Mar 31, 2025 | -431.66% |
| Dec 31, 2024 | 100.00% |
| Sep 30, 2024 | -1,104.41% |
| Jun 30, 2024 | -7,268.35% |
| Mar 31, 2024 | -1,133.49% |
| Dec 31, 2023 | -611,341.74% |
| Mar 31, 2023 | 97.76% |
| Mar 31, 2022 | -10,349.47% |
| Sep 30, 2021 | -154.42% |
| Jun 30, 2021 | 126.81% |
| Mar 31, 2021 | 89.92% |
| Dec 31, 2020 | -53.07% |
| Sep 30, 2020 | 26.13% |
| Jun 30, 2020 | 99.55% |
| Mar 31, 2020 | 97.26% |